Halyard Health Inc. (NYSE:HYH)’s share price dropped 1.5% during mid-day trading on Monday . The company traded as low as $33.83 and last traded at $33.93, with a volume of 210,349 shares. The stock had previously closed at $34.45.

HYH has been the topic of a number of research reports. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $33.00 price objective on the stock in a report on Friday, May 6th. JMP Securities reissued a “buy” rating on shares of Halyard Health in a report on Tuesday, April 12th. Stephens initiated coverage on shares of Halyard Health in a report on Friday, April 8th. They issued an “overweight” rating on the stock. TheStreet raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. Finally, Stifel Nicolaus raised their price objective on shares of Halyard Health from $32.00 to $37.00 and gave the stock a “buy” rating in a report on Tuesday, June 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $33.80.

The stock’s market cap is $1.57 billion. The firm’s 50-day moving average is $32.89 and its 200 day moving average is $29.14.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, May 4th. The company reported $0.53 EPS for the quarter, topping the Zacks’ consensus estimate of $0.34 by $0.19. The firm earned $385 million during the quarter, compared to the consensus estimate of $369.80 million. During the same quarter in the prior year, the firm posted $0.51 earnings per share. The business’s revenue for the quarter was down 2.3% compared to the same quarter last year. On average, analysts forecast that Halyard Health Inc. will post $1.66 EPS for the current fiscal year.

Other institutional investors recently bought and sold shares of the company. Wells Fargo & Company MN increased its position in Halyard Health by 73.8% in the fourth quarter. Wells Fargo & Company MN now owns 581,871 shares of the company’s stock valued at $19,440,000 after buying an additional 247,075 shares during the period. Cornerstone Capital Management Holdings LLC. bought a new position in Halyard Health during the fourth quarter valued at about $1,454,000. Mutual of America Capital Management LLC increased its position in Halyard Health by 2.8% in the fourth quarter. Mutual of America Capital Management LLC now owns 32,002 shares of the company’s stock valued at $1,069,000 after buying an additional 868 shares during the period. Liberty Mutual Group Asset Management Inc. increased its position in Halyard Health by 51.7% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 30,034 shares of the company’s stock valued at $1,004,000 after buying an additional 10,238 shares during the period. Finally, New York State Common Retirement Fund increased its position in Halyard Health by 168.1% in the fourth quarter. New York State Common Retirement Fund now owns 147,992 shares of the company’s stock valued at $4,944,000 after buying an additional 92,791 shares during the period.

Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.